Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2026 Jan 20;87(2):172-193.
doi: 10.1016/j.jacc.2025.10.051. Epub 2025 Nov 10.

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US

Mohit K Turagam  1 Arash Aryana  2 John D Day  3 Srinivas R Dukkipati  1 Troy Hounshell  4 Devi Nair  5 Andrea Natale  6 Stanislav Weiner  7 Jim W Cheung  8 Larry Chinitz  9 Frank Cuoco  10 Marcos Daccarett  11 Sanjay Dandamudi  12 Alok Gambhir  13 Maheer Gandhavadi  14 Jamie Kim  15 Mark D Metzl  16 Bradley Mikaelian  17 Darren Peress  18 Jorge E Romero  19 Javier Sanchez  20 David A Sandler  21 Naushad A Shaik  22 Michael Shehata  23 Sultan M Siddique  24 Abhinav Singh  25 Matthew J Singleton  26 Sri Sundaram  27 Yoel Vivas  28 Jonathan W Waks  29 Kenneth H Yamamura  30 Matthew Zipse  31 Joon Ahn  32 Obadah Al Chekakie  33 Mahmoud Ali  34 Nameer Ascandar  35 Sandeep Bansal  36 Andrew D Beaser  37 Jaskanwal Bisla  38 Scott Brancato  39 David J Callans  40 Peter Chang-Sing  41 Rashaad Chothia  42 Joseph Dell'Orfano  43 David B DeLurgio  44 Shephal K Doshi  45 Lynn Erickson  46 Sandeep Gautam  47 Venkateshwar Gottipaty  48 Sandeep Goyal  49 Sanjaya Gupta  50 Jamal Hajjari  51 John D Harding  52 Jessica Hennessey  53 Huy Ho  54 Ivan Ho  55 Jonathan C Hsu  56 Henry D Huang  57 Matthew Hutchinson  58 Rachel Kaplan  59 Sreekanth Karanam  60 Nayanjyoti Kaushik  61 David N Kenigsberg  62 Arfaat Khan  63 Bradley Knight  64 Jordan Leyton-Mange  65 Bernard Lim  66 Theodore J Maglione  67 Bobby Malik  68 Matthew McKillop  69 Donald Mehlhorn  70 Davendra Mehta  71 Suneet Mittal  72 Kent R Nilsson  73 Samuel Omotoye  74 Hakan Oral  75 Ragesh Panikkath  76 Apoor Patel  77 Christian Perzanowski  78 Anil Rajendra  79 Mansour Razminia  80 Samir Saba  81 Jose M Sanchez  82 Danish Iltaf Satti  83 Navinder Sawhney  84 Dinesh Sharma  85 Robert Sheppard  86 Madhurmeet Singh  87 Jasbir Sra  88 James E Stone  89 Ravi Sureddi  90 Matthew Taylor  91 Todd L Teigeler  92 Venkat Tholakanahalli  93 Amar Trivedi  94 Kevin M Trulock  95 Ganesh Venkataraman  96 Daniel Weitz  97 Brian D Williamson  98 Stephen L Winters  99 Jennifer M Wright  100 Richard Wu  101 David Yoo  102 Anthony Aizer  9 Daniel Dan Alyesh  27 Luciano Amado  11 Ryan Borne  17 Nagib Chalfoun  12 David Chang  15 Megan Davis  103 Ashkan Ehdaie  23 Paul Z Gerczuk  30 Jefferson H Lee  26 Gregory Michaud  29 Hiroshi Miyama  8 Sanghamitra Mohanty  6 Luis Mora  28 George Mounir  22 Nischala Nannapaneni  3 Jose Nazari  16 Graham Peigh  64 William H Sauer  19 Darren Sidney  10 Vivek Varughese  24 Wendy Tzou  31 Ugur Gurol  1 Vivek Y Reddy  104 MANIFEST-US Investigators
Affiliations
Multicenter Study

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US

Mohit K Turagam et al. J Am Coll Cardiol. .

Abstract

Background: Pulsed field ablation (PFA) is emerging as the preferred energy source for atrial fibrillation ablation, largely because of its promising safety profile, including lower risks of esophageal injury, pulmonary vein stenosis, and phrenic nerve injury. However, rare complications may only emerge after treating many thousands of patients.

Objectives: This study sought to determine the real-world utilization and safety profile of the pentaspline PFA catheter in the United States.

Methods: In this retrospective analysis, invitations were sent to U.S. centers performing PFA with the pentaspline catheter. Centers submitted data on patient demographics, procedural details, and adverse events (AEs). The main outcomes included the incidence of major and minor procedure-related AEs.

Results: Of the 435 centers contacted, 102 participated, averaging 5.1 operators per center (range 1-16 operators per center). Each center treated a median of 412 patients (range 26-1,961 patients), totaling 41,968 patients between February 2024 and July 2025. The median patient age was 68 years (range 17-99 years), and 56% were male. Most patients underwent first-time ablation (73%), primarily for paroxysmal (54%) or persistent atrial fibrillation (37%). Pulmonary vein isolation was performed in 93% of patients, with extravenous lesions on the posterior wall (57%), cavotricuspid isthmus (31%), or mitral isthmus (14%). Major AEs occurred in only 0.63% of patients, including cardiac tamponade (0.16%), vascular injury requiring intervention (0.18%), and stroke (0.10%). Importantly, no cases of esophageal fistula, persistent phrenic nerve paralysis, or pulmonary vein stenosis occurred. Mortality at 30 days was rare (0.04%), but there was a potential signal for rare (0.019%) unexplained sudden death/cardiac arrest. Rare AEs included coronary spasm (0.10%) and acute renal failure requiring dialysis (0.02%). Minor complications were reported in 2.05%, mainly vascular issues (0.96%), pericarditis (0.52%), and self-limited esophageal dysmotility (0.04%).

Conclusions: In a real-world setting of unselected U.S. patients, PFA demonstrated a safety profile consistent with preferentiality to functional myocardial tissue ablation, without evidence of esophageal fistula or pulmonary vein stenosis. The major complication rate was ∼0.6%-mostly vascular AEs and pericardial tamponade. Stroke (∼1 in 1,000) and death (∼1 in 2,000) were rare. These data indicate that the initial implementation of pentaspline PFA has been overall safe.

Keywords: atrial fibrillation; catheter ablation; pentaspline catheter; pulsed field ablation.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Turagam has served as a consultant to Abbott, Medtronic, and J&J MedTech. Dr Aryana has served as a consultant to/speaker for Abbott, Boston Scientific, Biotronik, Medtronic, and J&J MedTech. Dr Day has served as a consultant to/speaker for Boston Scientific and Abbott. Dr Dukkipati has received royalty payments from Boston Scientific; and has served as a consultant to Biosense-J&J MedTech and Boston Scientific. Dr Hounshell has served as a consultant to and on the advisory board of Boston Scientific. Dr Nair has served as a consultant to Biosense Webster, Boston Scientific Corporation, Johnson & Johnson, and Medtronic; and has received research grants from Abbott Laboratories, Adagio, Boston Scientific, Laminar, and Medtronic. Dr Natale has served as a consultant to Abbott, Biosense Webster, Biotronik, Boston Scientific, and iRhythm. Dr Weiner has served as a consultant to Abbott, Boston Scientific, Johnson and Johnson, and Medtronic; and has performed research for Bayer, Boston Scientific, Impulse Dynamics, Medtronic, Recor Medical, and V-Wave. Dr Cheung has served as a consultant to Biosense; has received research grant support from Boston Scientific; and has received fellowship grant support from Abbott, Biosense, Boston Scientific, and Medtronic. Dr Chinitz has received speaker fees from and served as a consultant to Abbott, Biotronik, Medtronic, and Biosense Webster. Dr Cuoco has served as a consultant to and performed research for Boston Scientific and Abbott. Dr Daccarett has served as a consultant to Boston Scientific. Dr Gambhir has received consulting fees from Abbott, Biosense Webster, and Boston Scientific; and has received speaker fees from Boston Scientific. Dr Gandhavadi has served as a speaker/consultant for Abbott, Medtronic, Boston Scientific, and Haemonetics. Dr Kim has received honoraria from Boston Scientific and Biosense Webster. Dr Metzl has served as a consultant for Atraverse, J&J MedTech, and Boston Scientific. Dr Mikaelian has served as a consultant for Boston Scientific and Johnson and Johnson. Dr Romero has received consulting fees from J&J MedTech, Boston Scientific, Abbott, AtriCure, and Sanofi; and has received research funding from Medtronic, J&J MedTech, and Boston Scientific. Dr Shaik has relationships with Boston Scientific, Medtronic, Abbott, Biotronik, Biosense Webster, and Agra Medical. Dr Shehata has received research grants from and served as a consultant to Boston Scientific and Abbott. Dr Siddique has served as a consultant to Boston Scientific. Dr Singleton has served as a consultant to Abbott, Biosense Webster, Boston Scientific, Haemonetics, and Medical Device Business Services. Dr Sundaram has served as a consultant to and on the Speakers Bureau of Medtronic, Abbott, and Boston Scientific; and holds equity interest in and serves on the Advisory Board of Heart Hero. Dr Vivas has served as a consultant for Abbott and Boston Scientific. Dr Waks previously served on the Advisory Board for Heartcor Solutions LLC; has served as a consultant to HeartBeam Inc and Heartcor Solutions LLC; and has received research funding from Anumana. Dr Zipse has served as a consultant to or on the Advisory Boards of Medtronic, Biosense Webster, and Philips; and has received honoraria for Fellow Education Lectures from Boston Scientific. Dr Ali has served as a speaker for Medtronic. Dr Bansal has served as a consultant to Medtronic and Johnson and Johnson. Dr Beaser has served as a speaker for Abbott. Dr Callans has consulted and lectured for Boston Scientific. Dr Chothia has served as a consultant to a Medtronic pacemaker implant training site. Dr DeLurgio has served as a consultant to/speaker for Boston Scientific. Dr Doshi has served as a consultant to/on the Advisory Boards of Abbott, Boston Scientific, and J&J MedTech. Dr Goyal has relationships with Medtronic, Boston Scientific, Abbott, and Siemens. Dr Gupta has received modest consulting/teaching honoraria from Boston Scientific, Abbott, and Cordis. Dr Hennessey has served as a consultant to and speaker for Boston Scientific; has served as a consultant to and educational speaker for Abbott; and has served on the Advisory Board of Medtronic. Dr Hsu has received honoraria from Medtronic, Abbott, Boston Scientific, Biotronik, Janssen Pharmaceuticals, Bristol Myers Squibb, Pfizer, Sanofi, Altathera Pharmaceuticals, Milestone Pharmaceuticals, Zoll Medical, iRhythm, Edwards Lifesciences, Viz.ai, Atraverse Medical, and Biosense Webster; and holds equity interest in Vektor Medical. Dr Huang has received a research grant and speaker honorarium from and served as a consultant to Biosense Webster. Dr Kaplan has served as a consultant to Abbott, Boston Scientific, and Medtronic; and has received royalties from UptoDate. Dr Kenigsberg has served as Chief Medical Officer for Electrophysiology of Pulse Biosciences; has served as a consultant to Abbott and Johnson and Johnson; and is a shareholder in Cortex. Dr Knight has served as a consultant to Abbott, Atraverse, Baylis, Biosense Webster, Biotronik, Boston Scientific, iRhythm, and Medtronic. Dr Leyton-Mange has served as a consultant to Biosense Webster and Heart Rhythm Clinical Research Solutions. Dr Maglione has received honorarium from Biosense Webster. Dr Mittal has served as a consultant to Boston Scientific and Medtronic. Dr Nilsson has relationships with Abbott and Biosense Webster. Dr Omotoye has served as a consultant to Biosense Webster and Attune Medical. Dr Oral is a member of the Scientific Advisory Board of Arga Medtech. Dr Patel has served as a speaker for/consultant to Biosense Webster. Dr Rajendra has served as a consultant to Boston Scientific, J&J MedTech EP, and CardioFocus. Dr Razminia has served as a consultant to Abbott and Boston Scientific. Dr Saba has received research support from Abbott and Boston Scientific; and has served as a consultant to Boston Scientific and Medtronic. Dr Sharma has served as a consultant to Medtronic, Boston Scientific, and Abbott. Dr Tholakanahalli has served as a consultant to Boston Scientific, Abbott Inc, J&J Med Tech, Imricor, Caylan, Aquaheart, Kobara Corp, Hicky Inc, and Patvja LLC. Dr Trivedi has served as a consultant to Medtronic and Abbott. Dr Trulock has served as a consultant/advisor for Boston Scientific, Medtronic, and Abbott. Dr Winters has performed research for Biosense Webster. Dr Wright has served as a consultant to/speaker for J&J MedTech. Dr Aizer has served as a consultant to Biotronik and Ulysses Medical. Dr Alyesh has served as a consultant to Abbott Laboratories, J&J MedTech, and Heart Rhythm Clinical Research Solutions. Dr Amado has served as a consultant to Boston Scientific. Dr Chalfoun has served as a speaker for Medtronic and Boston Scientific; and has served as a speaker for and consultant to Atricure. Dr Chang has received honoraria from Boston Scientific and Biosense Webster. Dr Michaud has served as a consultant to Abbott, Arrhythmia Education Inc, J&J MedTech, Boston Scientific, and HMP Education. Dr Mora has served as a consultant to Abbott and Boston Scientific. Dr Mounir has served as a consultant to Biosense Webster. Dr Sauer has received consulting fees from J&J MedTech, Boston Scientific, and Abbott; and has received research funding from Medtronic and J&J Med Tech. Dr Tzou has received consulting fees, speaker honoraria, or grant funding from or served on Advisory Boards for Abbott, Biosense Webster, Boston Scientific, Biotronik, Kardium, and Medtronic. Dr Sidney has served as a consultant to and performed research for Boston Scientific and Abbott. Dr Reddy has received grant support from and is an unpaid consultant to Boston Scientific; has served as a consultant for and has equity in Anumana, APN Health, Append Medical, Aquaheart, Atacor, Atraverse, Autonomix, BioSig, CardiaCare, Cardiofocus, CardioNXT/AFTx, Circa Scientific, CoRISMA, Cortex-Boston Scientific, Corvia Medical, Dinova-Hangzhou DiNovA EP Technology, East End Medical, EP Frontiers, Field Medical, Focused Therapeutics, Heartbeam, HRT, Intershunt, Javelin, Kardium, Laminar-J&J MedTech, LuxMed, Medlumics, Orchestra Biomed, PhysioMap, Pulse Biosciences, Restore Medical, Sirona Medical, SoundCath-Boston Scientific, and Volta Medical (unrelated to this manuscript); has served as a consultant to Abbott, Adagio Medical, AtriAN, BioTel Heart, Biotronik, BTL, Cairdac, Cardionomic, Conformal Medical, CoreMap, Fire1, Impulse Dynamics, J&J MedTech, Medtronic, Novartis, Novo Nordisk, Philips, and SmartValves (unrelated to this work); and has equity in DRS Vascular, Manual Surgical Sciences, Newpace, Nyra Medical, Soundcath, Surecor, and Vizaramed (unrelated to this work). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Publication types

LinkOut - more resources